EUVIMED · CrossrefZeitschrift
Advanced Drug Delivery Reviews
ISSN 0169-409X · Elsevier BV
Neueste Artikel
Peroxidase-mimicking Nanozymes for Redox Monitoring and Regulation in Cancer Theranostics
Additive manufacturing as a unifying platform across drug discovery, drug delivery, and theranostics
Anti-PEG antibodies in drug delivery: From origins to mitigation strategies
Mapping nanodelivery design for liver fibrosis: A mechanism-informed framework for functional integration
From acute intervention to chronic management: biopharmaceutical barriers and advanced formulation strategies for peroral metronomic chemotherapy
Material-centric design of organ-on-a-chip systems: Towards industrial translation and mass manufacturing
A toolbox to optimize and scale up microfluidic production of lipid-based nanoparticles
From conventional biologics–device combination products to advanced therapies: current state and future trends in patient-centric delivery
Molecular design and delivery of extracellular and membrane protein degradation chimeras
Engineering peptide-drug conjugates for targeted cancer therapy: design principle, theranostic imaging, and translational challenges
Engineering responsive polymeric drug delivery systems via bioorthogonal and click chemistry: From molecular design to function
Corrigendum to “Near-infrared fluorescence imaging-guided targeted drug delivery in gastric tumors: From molecular design to clinical translation” [Adv. Drug Deliv. Rev. 235 (2026) 115891]
Adipose tissue-on-Chip platforms for disease modelling, drug discovery and pharmacokinetic modelling
Microfluidics in heart-on-a-chip platforms for cardiovascular drug discovery and cardiotoxicity assessment
Fibrosis: Bridging fundamental mechanisms to precision medicine via advanced therapeutics
Nanozyme-mediated redox and immune homeostasis in osteoarthritis and rheumatoid arthritis
Poly(2-oxazoline)s and poly(2-oxazine)s: An overview of stealth properties, pharmacokinetics, and immunogenicity
Gas therapeutics for wound healing: Therapeutic potential of oxygen and nitric oxide
Redox-responsive peptide assemblies for precision theranostic
Bioorthogonal chemistries for theranostics and radioconjugates
Bioorthogonal chemistry conjugates: ADCs and beyond
Nanoparticles for cardiovascular diseases: identifying and overcoming barriers in translating preclinical success to clinical applications
Engineering human brain microphysiological systems for alzheimer’s disease (AD) and chronic traumatic encephalopathy (CTE) modeling and drug testing: translational promise, limitations, and future directions
Bioelectrical and optogenetic modulation for neuroimmune therapeutics
Editorial Board
From PEG to randomized PEG: a macromolecular strategy tackling PEG immunogenicity
Beyond PEG: Re-Engineering stealth-polymers to do more than just hide
Regulatory landscape for inhaled biologics: Considerations and guidelines
Star polymer nanomedicine: From orthogonal synthetic chemistry to precision in therapeutic interventions
Bioorthogonal chemistry-enabled multiscale engineering of cancer immunotherapy
Jahrgänge
2027 · 52026 · 1442025 · 1402024 · 1332023 · 2122022 · 2902021 · 3382020 · 1522019 · 1732018 · 1852017 · 1702016 · 2132015 · 1882014 · 1502013 · 1782012 · 1972011 · 1282010 · 1402009 · 1552008 · 1592007 · 1322006 · 1222005 · 1732004 · 1462003 · 1292002 · 1362001 · 1672000 · 981999 · 1021998 · 1161997 · 1331996 · 1071995 · 871994 · 531993 · 631992 · 371991 · 531990 · 311989 · 381988 · 33
EUVIMED